# Macro Bank Inc.: financial statements, quarterly

BMA · NYSE · CIK 1347426 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bma.md) · [Financials](/companies/bma/financials.md) · [Filings](/companies/bma/filings.md) · [Insiders](/companies/bma/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bma/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2016-12-31) | period not labelled (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [148](/filings/0001193125-20-144107.md) | [172](/filings/0001193125-21-140667.md) | [413](/filings/0001193125-22-127903.md) | [590](/filings/0001193125-23-126614.md) | [2,414](/filings/0001193125-24-122871.md) | [4,094](/filings/0001193125-25-087225.md) | [5,086](/filings/0001193125-25-087225.md) | [3,015](/filings/0001193125-25-087225.md) | [2,864](/filings/0001193125-25-087225.md) |
| Total assets | $bn | [295](/filings/0001193125-19-161189.md) | [338](/filings/0001193125-19-161189.md) | [540](/filings/0001193125-20-144107.md) | [606](/filings/0001193125-21-140667.md) | [1,169](/filings/0001193125-22-127903.md) | [1,947](/filings/0001193125-23-126614.md) | [6,509](/filings/0001193125-24-122871.md) | [14,630](/filings/0001193125-25-087225.md) | [14,492](/filings/0001193125-25-087225.md) |
| Total liabilities | $bn | [248](/filings/0001193125-19-161189.md) | [266](/filings/0001193125-19-161189.md) | [447](/filings/0001193125-20-144107.md) | [462](/filings/0001193125-21-140667.md) | [940](/filings/0001193125-22-127903.md) | [1,480](/filings/0001193125-23-126614.md) | [4,914](/filings/0001193125-24-122871.md) | [10,190](/filings/0001193125-25-087225.md) | [10,442](/filings/0001193125-25-087225.md) |
| Shareholders' equity | $bn | [72.2](/filings/0001193125-20-144107.md) | [71.4](/filings/0001193125-19-161189.md) | [93.7](/filings/0001193125-20-144107.md) | [144](/filings/0001193125-21-140667.md) | [229](/filings/0001193125-22-127903.md) | [467](/filings/0001193125-23-126614.md) | [1,595](/filings/0001193125-24-122871.md) | [4,439](/filings/0001193125-25-087225.md) | [4,049](/filings/0001193125-25-087225.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 639,413,408 at 2024-12-31, from the cover of the [20-F filed 2025-04-21](/filings/0001193125-25-087225.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.